Hyperpigmentation Treatment Market Size & Outlook, 2026-2034

Hyperpigmentation Treatment Market Overview

The global hyperpigmentation treatment market size is estimated at USD 1.46 billion in 2025 and is projected to reach USD 2.55 billion by 2034, growing at a CAGR of 6.45% during the forecast period. Remarkable growth of the market is due to the heightened consumer awareness, advancements in dermatological treatments, as well as growing emphasis on skin aesthetics.

Key Market Trends & Insights

• North America held a dominant share of the global market, accounting for 52.86% share in 2025.
• The Asia Pacific region is growing at the fastest pace, with a CAGR of 8.26%.
• Treatment Type: The topical treatments (creams and Serums) segment is expected to register the fastest CAGR growth of 7.31%.
• Application: The age spots segment held the highest market share of 37.11% in 2025.
• The U.S. dominates the global market, valued at USD 676.80 million in 2024 and reaching USD 717.50 million in 2025.

Graph: U.S. Market Revenue Forecast (2022 – 2034)

Source: Straits Research

Market Size & Forecast

• 2025 Market Size: USD 1.46 billion
• 2034 Projected Market Size: USD 2.55 billion
• CAGR (2025 to 2034): 6.45%
• Dominating Region: North America
• Fastest-Growing Region: Asia Pacific

The global hyperpigmentation treatment market encompasses a diverse range of therapeutic solutions aimed at reducing excess melanin production and restoring even skin tone, playing a vital role in dermatological care and aesthetic medicine. By treatment type, the market is segmented into topical and procedural treatments. Topical treatments include hydroquinone-based creams, retinoids, vitamin C serums, and kojic acid creams, which are primarily used for mild to moderate pigmentation. Procedural treatments consist of laser and light-based therapies such as Q-switched lasers, fractional lasers, and intense pulsed light (IPL), as well as chemical peels including glycolic acid, salicylic acid, and TCA peels, alongside microneedling and platelet-rich plasma (PRP) therapies that enhance collagen production and skin renewal. By application, the market is categorized into age spots, melasma, post-inflammatory hyperpigmentation (PIH), freckles, and others, with melasma and PIH accounting for a share due to their prevalence and recurrence. Continuous advancements in combination therapies, customized formulations, and device-based procedures, along with the growing adoption of AI-driven skin analysis and rising consumer awareness of aesthetic dermatology, are propelling the global market toward steady growth.

Latest Market Trends

Rise of Tranexamic Acid in Skincare

The growing focus on efficient and accessible hyperpigmentation treatments has emerged as a major trend due to its efficacy in targeting stubborn pigmentation issues such as melasma and post-inflammatory hyperpigmentation. According to the data reported in Beauty Pie, tranexamic acid is one of the second biggest ingredient trends of 2025. An increase in interest towards the tranexamic acid was witnessed by 107% in the latter half of 2024, hence positioning it as the second most used skincare ingredient, surpassing other most widely used actives, such as azelaic acid.

Such a factor depicted a broader movement towards balancing the treatment efficacy with consumer accessibility and also underscored the strategic shift in the skincare sector towards the evidence-based, high-impact formulations, which enhance the growth of targeted hyperpigmentation solutions.

Regulatory-Driven Innovation Boosts Alternative Hyperpigmentation Actives

The strict regulations on kojic acid in the European Union and the UK have emerged as a market trend by driving innovation in the skincare industry. For example, in April 2025, as per the data reported in Cosmetic Ingredient Review, kojic acid is limited to a maximum concentration of 1% in face as well as hand products, which encouraged brands to reformulate and explore safer and more efficient alternatives.

Such a factor reflected the transition towards the evidence-based, consumer-safe activities that delivered tangible results while complying with the evolving regulatory standards.

To get more insights about this report Download Free Sample Report

Hyperpigmentation Treatment Market Drivers

Expansion of Dermatology Clinics and Aesthetic Centers

The rapid expansion of dermatology clinics as well as aesthetic centers, acts as a market growth, as it depicts the increased consumer demand for non-invasive cosmetic procedures. For example, in April 2025, as per the data reported in M Health Fairview Clinic, a USD 1.5 million remodel at the M Health Fairview Clinic in Bloomington, Minnesota, aimed at enhancing access to general dermatology, cosmetic, and skin cancer care, which reflected the growing investment in the dermatology infrastructure.

Such expansion not only met the rising demand for dermatological services but also signified a broader transformation in the healthcare landscape, where specialized care is becoming more accessible to a wider population.

Market Restraint

Side Effects and Complications Associated with Hyperpigmentation Treatments

The side effects as well as complications that are associated with certain hyperpigmentation treatments, hinder the market growth. As per the data reported in the National Library of Medicine, approximately 10% of users had reported adverse reactions, including skin irritation, erythema, and post-inflammatory hyperpigmentation, which have hindered the widespread adoption.

Such safety concerns underscored the demand for continuous innovation and the development of safer, more efficient treatments to mitigate risks, and also enhanced patient confidence in the hyperpigmentation therapies.

Market Opportunities

Growing E-Commerce and Online Distribution of Skincare Products

The rapid expansion of e-commerce and online distribution channels acts as a market opportunity for the skincare industry. In addition, the rise of social commerce, influencer-driven market, and personalized digital experiences is enabling brands to engage more effectively with consumers. Such a factor underscored the importance for skincare companies to adopt advanced digital strategies and optimize their e-commerce platforms to capture the growing online consumer base.

Regional Analysis

The North America region dominated the market with a revenue share of 52.86% in 2025. The growth is attributed to factors such as the presence of well-established dermatology clinics as well as cosmetic centers.

The hyperpigmentation treatment market in the U.S. is widely driven by the support of the government towards clinical research on skin health for improving healthcare outcomes, which also enhances the market growth. As per the U.S. FDA, several new treatments were approved, including the advanced topical creams as well as laser therapies that further expand the market growth.

Asia Pacific Market Insights

The Asia Pacific region is the fastest-growing region with a CAGR of 8.26% during the forecast timeframe. The growth is attributed to factors such as a large and growing population. In addition, several brands and products in the region are focusing on dermatological health via public awareness campaigns, which further boosts the demand for hyperpigmentation treatments.

The rising popularity of personalized skincare solutions targeting skin brightening and pigmentation correction, fueled by increasing consumer demand for tailored dermatological treatments, enhances the market growth. Chinese consumers are increasingly adopting AI-powered skin analysis apps offered by brands like Perfect Diary, which recommend customized serums and treatment routines to specifically address melasma, age spots, and post-inflammatory hyperpigmentation.

Pie Chart: Regional Market Share, 2025

Source: Straits Research

Europe Market Insights

The hyperpigmentation treatment market in Europe is propelling due to technological advancements in the treatment options, such as laser therapies, as well as topical agents, which have further contributed to market expansion.

The rising demand for natural and clinically tested topical formulations that cater to sensitive skin while effectively reducing pigmentation drives the market growth. For example, brands such as Babor offer scientifically validated serums and creams containing ingredients such as niacinamide and vitamin C, which are gaining popularity among German consumers who prefer safe, dermatologist-recommended skincare solutions.

Middle East and Africa Market Insights

A driver for the Middle East and Africa hyperpigmentation market is the growing emphasis on sun protection and skin brightening solutions, driven by high UV exposure and cultural preferences for uniform skin tone. For example, consumers in countries like the United Arab Emirates and Saudi Arabia are increasingly using combination therapies that include SPF-enriched brightening creams and laser treatments to prevent and manage age spots and post-inflammatory hyperpigmentation.

The increasing demand for dermatologically approved treatments targeting post-inflammatory hyperpigmentation caused by acne and skin injuries, driven by a growing awareness of skin health and cosmetic appearance, enhances the market growth. South African consumers are increasingly turning to clinically tested serums with ingredients like kojic acid and vitamin C, as well as in clinic procedures such as chemical peels, to effectively reduce dark spots and achieve an even skin tone.

Latin America Market Insights

The expanding availability of affordable dermatology clinics and aesthetic centers in urban areas, which makes professional treatments more accessible to a wider population, enhances the market growth. For example, in Brazil and Argentina, the growth of local clinics offering microneedling, chemical peels, and laser-based pigmentation correction has enabled more consumers to seek effective solutions for age spots, melasma, and post-inflammatory hyperpigmentation.

The increasing demand for natural and plant-based skincare formulations that cater to consumers seeking safe and gentle alternatives for pigmentation management enhances the market growth. The brands are developing serums and creams containing botanical extracts like licorice root, aloe vera, and chamomile, which are gaining popularity among consumers aiming to treat melasma and dark spots without harsh chemicals.

Treatment Type Insights

The topical treatments (Creams and Serums) segment is anticipated to grow at a CAGR of 7.31% during 2026 - 2034. The growth is attributed to the increasing preference of consumers for the non-invasive treatments, easy to use skincare solutions that target hyperpigmentation and uneven skin tone, coupled with the rising awareness about dermatologically tested products as well as availability of advanced formulations enriched with actives, such as tranexamic acid, niacinamide and vitamin c.

The procedural treatments dominated the market in 2025, due to the growing preference for targeted pigment removal technologies that enable precise melanin disruption at cellular levels, minimizing recurrence and improving skin tone uniformity in resistant pigmentation conditions such as melasma and post-inflammatory hyperpigmentation.

Application Insights

The age spots segment dominated the market with a revenue share of 37.11% in 2025. This growth is attributed to the increasing consumer awareness about skin aging, rising adoption of preventive skincare routines and availability of advanced formulations targeting age spots, which further enhance the market growth.

The post-inflammatory hyperpigmentation (PIH) segment is anticipated to register the fastest CAGR of 7.56% during the forecast period, driven by the rising prevalence of acne, eczema, and cosmetic procedures that often lead to pigmentation irregularities.

Source: Straits Research 

Competitive Landscape

The global hyperpigmentation treatment sector is highly fragmented in nature due to the diverse range of multinational companies and emerging dermatological brands. The top players are L'Oréal S.A., Unilever, Beiersdorf AG, Candela Corporation, and others.

M. Collin: An emerging market player

G.M. Collin offers products with an aim of providing advanced product formulation as a dermo-corrective skin care solution.

• In June 2025, G.M. Collin launched a dark spot serum, which is designed to target hyperpigmentation, including dark spots as well as signs of aging.

List of key players in Hyperpigmentation Treatment Market

1. L'Oréal S.A.
2. Unilever
3. Beiersdorf AG
4. Candela Corporation
5. Obagi Cosmeceuticals LLC
6. SkinCeuticals
7. La Roche-Posay
8. Vivier Pharma Canada
9. iS Clinical
10. BIODERMA
11. CP Skin Health Group, Inc.
12. ISDIN
13. Shiseido Co., Ltd.
14. Uriage
15. Episciences, Inc.
16. Johnson and Johnson Innovation LLC
17. Procter and Gamble, Plz
18. Menarini Asia-Pacific Pte. Ltd.
19. Topicals
20. Image Skincare
21. Others

To get more findings about this report Download Market Share

Strategic Initiatives

• September 2025: Swiss skincare brand Cellcosmet introduced two innovative products, Brightener-XT and the reformulated Ultra Brightening Elaso-Collagen-XT, aimed at combating hyperpigmentation.
• February 2025: Alkem Laboratories launched Kojiglo serum in India, which targets facial hyperpigmentation.
• January 2025: Asaya launched MelaMe, a pioneering technology aimed at resolving hyperpigmentation in Indian skin tones.